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I.   Abbreviations 
 
 
AML – acute myeloid leukemia 
CLSF – C-type lectin superfamily 
EBV – Epstein Bar virus 
ERK – extracellular signal regulated kinase 
EST – expressed sequence tag 
GVHD – graft versus host disease 
HLA – human leukocyte antigen 
IgSF – immunoglobulin superfamily 
ITAM – immunoreceptor tyrosine-based activation motif 
ITIM – immunoreceptor tyrosine-based inhibition motif 
LRC – leukocyte receptor gene complex 
KIR – killer cell immunoglobulin-like receptor 
LAIR – leukocyte-associated immunoglobulin-like receptor 
LENG – LRC-encoded novel genes 
LILR – leukocyte immunoglobulin-like receptor 
MAPK – mitogen activated protein kinase 
MHC – major histocompatibility complex 
NK – natural killer 
NKC – natural killer cell gene complex 
ORF – open reading frame 
PCR – polymerase chain reaction 
PLC – phospholipase C 
PVDF – polyvinyliden difluoride 
RT – reverse transcriptase 
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SAP – slam associated adaptor protein 
SDS – sodium dodecyl sulphate 
SH2 – src homology 2 domain 
SHP – src homology phosphatase 
TCR – T cell receptor 
 
 
 
 
 
 
 
 
 
II.   Introduction 
 
 
2.1.   Natural killer cells and target recognition 
In 1975, Kiessling et al. reported that spleen cells from adult, non-immunized mice 
displayed spontaneous lytic activity against certain tumor cell lines. The cytotoxic 
activity was excerted by a group of small undefined lymphocytes termed natural killer 
(NK) cells 1,2. Natural killer (NK) cells are specialized in detecting aberrant cells in the 
body such as tumor transformed or virally infected cells, and the NK cells act as a first 
line of defense before the development of adaptive immunity. The NK cell induces lysis 
of the target cell in one of two ways: by generating cytokines, notably interferon γ, which 
activate other components of the immune system or by killing the target cell directly, a 
mechanism referred to as natural cytotoxicity. The function of the NK cell is not limited 
to being effector cells of the innate immune response, NK cells also act as regulatory 
cells and interact with dendritic cells in ways that seem to decide if and when adaptive 
immune responses should be made 3. Great effort has been put forth to identify the 
receptors expressed by NK cells, the means by which the NK cells interact with their 
environment. Receptors are transmembrane anchored proteins, and during the past few 
years a plethora of new receptors expressed by NK cells have been identified. Structually, 
 6
most NK cell receptors are either members of the immunoglobulin superfamily (IgSF) or 
the C-type lectin superfamily (CLSF). The NK cell receptors can also be divided into two 
groups according to whether they transduce signals that inhibit or activate the NK cell. 
Primarily the receptors have been studied in the human and in rodents. 
 
2.2.   Killer cell inhibitory receptors (KIR) 
In the mid 1980s experiments in mouse performed by Ljunggren and Kärre 4 and later in 
human 5-7, revealed that NK cells preferentially kill cells lacking the expression of MHC 
class I molecules, and based on these experiments the existence of inhibitory receptors 
regulating NK cell activation was predicted. The first killer cell immunoglobulin-like 
receptors (KIR) in human were identified in 1995 8,9, and a surprising feature of the new 
family of receptors was the existence of both activating and inhibitory variants possibly 
recognizing the same ligands, HLA class I. Stimulation of the inhibitory receptors 
blocked the intracellular pathways that led to NK cell activation, and apparently a balance 
between stimulation and inhibition dictated the nature of the immune response 10. NK cell 
tolerance of self was produced by the inhibitory signals overriding the activating signals 
when the cell interacted with a healthy autologus cell. It was also thought that NK cells 
killed target cells lacking MHC class I by default. However, this notion failed to explain 
why NK cells do not kill erythrocytes, which in humans do not express HLA class I. The 
recent identifications of a host of activating receptors such as NKp46, NKp30, NKp44 
and the lectin-like NKG2D seem to resolve the problem of target recognition 11-14. Other 
triggering surface receptors expressed by NK cells seem to rely on simultaneous co-
engagement of another triggering receptor, and they appear to serve both activating and 
inhibitory functions depending on the availability of substrates for downstream signaling 
events. Two such receptors are 2B4 and NTB-A 15,16, they contain tyrosine based motifs 
in their cytoplasmic domains permitting association with SLAM-associated adaptor 
protein (SAP). Mutation in the SAP gene seen in human X-linked lymphoproliferative 
disease, results in life threatening infections with Epstein–Barr (EBV) and EBV-
associated B-cell malignancies. In the absence of SAP both receptors convey inhibitory 
signals resulting in NK cell inactivation 15,17. 
 
The KIR receptors recognize different different allelic groups of HLA-A, -B or -C 
molecules 8,18-20. Importantly, each type of KIR receptor is expressed only by a subset of 
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NK cells. Each NK cell express at least one receptor specific for a self HLA class I 
molecule, and some data suggests that the coexpression of two or more receptors specific 
for HLA class I is rare 21,22. This allows the whole NK cell pool to detect the loss of even 
a single HLA class I allelle on a cell, an event that frequently occurs on tumor 
transformed cells.  However, KIR2DL4 a KIR family member that shares structural 
features with both activating and inhibitory receptors, is uniquely expressed by all NK 
cell clones 23. Contrary to the high specificity of the T-cell receptor, the KIR receptors 
proved to have a much broader specificity for MHC class I-alleles, e.g. a single receptor 
can recognize a majority of known allelic variants of HLA-C. Moreover, several 
observations indicate that the sequence of the peptide presented by the MHC class I 
molecule influences the binding of the different KIR members, and crystallographic 
structures show that the KIR receptor directly interacts with side chains belonging to both 
the MHC class I molecule and the peptide 24,25. 
                                    
Figure 1: 
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Ribbon diagram of the KIR2DL2/HLA-Cw3 complex. The D1 and D2 Ig-domains of KIR2DL2 are colored 
blue, the α1, α2, and α3 domains of HLA-Cw3 are in yellow, the β2m molecule is violet and the presented 
peptide is colored red. (The diagram is constructed using Cn3D; http://www.ncbi.nlm.nih.gov/Structure/ 
CN3D/cn3d.shtml, based on crystal structures; GenBank accession number 1EFX).                     
 
2.3.   Intracellular signaling 
The activating KIR receptors transmit signaling by binding to DAP12, a small 
transmembrane anchored adaptor protein that possesses an immunoreceptor tyrosine–
based activation motif (ITAM) in the cytoplasmic domain. Phosphorylation of the ITAM 
facilitates the recruitment of tyrosine kinases Syk and Zap70. Downstream events include 
the phosphorylation of SLP-76, 3BP2, Shc, PI3-kinase, phospholipase C (PLC)-γ1 and 
PLC-γ2, the mobilization of Grb2, linker for the activation of T cells (LAT), Vav-1 and 
Vav-2, the elevation if intracellular Ca2+  levels, and the activation of Rho, Ras, p38, 
mitogen activated protein kinase (MAPK) and extracellular signal regulated kinase 
(ERK) 26-30. 
 
 
 
Figure 2: 
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A cartoon model of the activating KIR function. A prototypic 2 Ig-domain KIR is depicted, along with a 
Src family kinase and tyrosine substrates known to be in the DAP12 pathway. Cross-linking of activating 
KIRs leads to rapid and transient tyrosine phosphorylation of DAP12, although it is still unclear which 
tyrosine kinase is responsible. Upon phosphorylation, DAP12 acts as a recruitment point for the 
Syk/Zap70-family of kinases. The ITAM of DAP12 is colored green; SH2 represents Src homology 2 
domain; CAT, catalytic domain. 
 
In contrast, the inhibitory KIR receptors transduce intracellular signaling through a pair 
of  immunoreceptor tyrosine-based inhibition motifs (ITIM) present in the cytoplasmic 
domain of the receptor. Ligation of the ITIM-bearing receptor results in the 
phosphorylation of the ITIMs and recruitment of the tyrosine phosphatases SHP-1 and 
SHP-2.  The substrates of these phosphatases are still not identified, but they may depend 
upon the type of activating receptor being modulated 28. However, SHP-1 possibly 
dephosphorylates ITAM polypeptides, Zap70, Syk, Vav-1 and other adaptor proteins 
responsible for the recruitment of downstream signaling molecules such as LAT and 
SLP-76.  
 
2.4.   Natural killer cell lectin-like receptors 
In human the receptors that mediate NK cell inhibition were termed KIRs, but one failed 
to characterize KIR homologs in rodents. In contrast, rodents rely on the expanded Ly49 
gene family to recognize MHC. The Ly49s are type II transmembrane glycoproteins, and 
are composed of an extracellular c-type lectin like domain connected to the 
transmembrane and intracellular domains by a stalk region 31. The receptors exist 
exclusively as homodimers on the cell surface. Remarkably, even though KIRs and 
Ly49s are functional analogs they are structurally unrelated. Rodents and humans, it 
seems, developed different means to solve similar problems. The Ly49s recognize the 
MHC class I molecules H-2D and H-2K 32,33, and the repertoire of receptors expressed by 
an individual NK cell includes both activating and inhibitory Ly49s. The inhibitory 
Ly49s possess cytoplasmic ITIMs, and the activating variants contain a charged amino 
acid in the transmembrane domain, allowing association with the adaptor molecule 
DAP12 34. The genomes of non-rodent mammals, including humans, contain a single 
Ly49-like gene 35. The Ly49 variant in human is considered to be a pseudogene, although 
it appears to be functional in other species like orangutan, baboon and cow 36,37.  
 
2.4.1.   Ly49 
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The Ly49 gene family is clustered in the most telomeric region of the NK gene complex 
(NKC), localized on chromosome 6 in mice and on chromosome 4 in rats. However, 
different strains of mice differ significantly in the number of Ly49 genes as well as their 
sequences. The Ly49 cluster has been studied extensively in C57BL/6 mice, and the 
genomic sequence includes 15 complete Ly49 genes (Ly49a-k, m, n, q and x) and 4 gene 
fragments. Of these, 11 cDNA clones encoding functional receptors have been isolated 
31,38. The organization of the NKC has not been fully characterized in rats, but studies are 
well underway to reveal its structure (Nylenna et al, 2004). 
 
The lack of KIR receptors in rodents was a bit of a mystery, and numerous attempts to 
identify orthologs were made. Finally, it was concluded that Ly49 genes predate the 
divergence of placental mammals, but expansion of the gene family was unique to the 
rodent lineage since they lacked KIR receptors. In non-rodent mammals however, KIR 
receptors replaced the function of the Ly49 gene and expanded in a similar manner. The 
rapid evolution of the genes probably reflected the changing selection by pathogens. 
Supposedly, the KIR receptor was lost from the genome of the mouse lineage sometime 
during the past 100 million years 39. 
 
2.4.2.   CD94/NKG2 
A third family of MHC-specific receptors, CD94/NKG2, are lectin-like, disulfide-linked 
heterodimers expressed on both human and rodent NK cells. The CD94 subunit is 
invariant, but NKG2 constitutes a family of at least four members; the inhibitory receptor 
NKG2A, and the activating receptors NKG2C, NKG2D and NKG2E 19. CD94/NKG2A 
binds the non-classical class I molecule Qa-1b in mice 40 and HLA-E in humans 41. These 
non-classical molecules preferentially present leader peptides derived from classical 
MHC class I molecules, and thus are indicators of normal expression of MHC class I. 
NKG2D recognizes MICA and MICB in humans 42, MHC class I homologs that are 
upregulated on transformed or virally infected cells. Human NKG2D also binds ULBPs, 
a group of proteins that bind cytomegalovirus glycoprotein UL16 43. Rodent homologs of 
MICA and MICB have not been identified, but other molecules with weak homology to 
MHC class I including RAE-I and H-60 serve as ligands for mouse NKG2D 44. 
 
2.5.   The extended family of immunoglobulin-like receptors 
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The identification of numerous new receptors with structual and functional similarity to 
the KIR receptors have added to the complexity of NK cell interaction, but although 
numerous, signal transduction itself seems to converge on a few common biochemical 
pathways. Although several names have been assigned to these receptors, most have 
acquired official HUGO names. The majority of these new receptors in human belong to 
the leukocyte Ig-like receptor (LILR) family. Similar to the KIRs some of these receptors 
recognize MHC class I molecules. 
 
2.5.1.   Leukocyte immunoglobulin-like receptors 
The LILR family members are glycoproteins with an extracellular ligand binding region 
composed of two, three or four Ig-like domains. The LILR family includes both 
inhibitory and activating members. The inhibitory variants have two or four ITIM motifs 
in their cytoplasmic region, and the activating receptors preferably associate with the 
FcεRIγ 45,46. The LILR receptors may modulate both innate and adaptive immunity as 
they exhibit an exceptionally wide expression pattern. LILR variants are found on 
myeloid cells and granulocytes as well as subsets of T, B and NK cells 45. Little is known 
about the genetic control of LILR transcription, although preliminary data suggests that 
some of the LILR variants show similar clonal expression pattern to KIRs 47. LILRB1, 
LILRB2 and LILRA1 recognize HLA class I molecules. However, the LILR receptors 
are more promiscuous as they recognize a large number of HLA class I alleles, and in 
addition LILRB1 and LILRB2 also recognize nonclassical and viral orthologs of HLA 
class I 47-50. The Gp49, NILR and PIR family of receptors are rodent genes most related 
to the human LILR family 51-54. 
 
2.5.2.   The human IgA receptor 
The human IgA receptor, CD89, has two extracellular Ig-like domains, and a short 
cytoplasmic region devoid of any signal transduction domains. However, an arginine is 
present in the transmembrane region permitting association with the FcεRIγ 55.  FcεRIγ 
bears an ITAM motif in the cytoplasmic domain, allowing activatory functions. The 
receptor binds both IgA subclasses with low affinity, IgA1 and IgA2 differ by the 
absence of a thirteen amino acid sequence in the hinge region of the IgA2 molecule 56. 
The receptor is expressed on neutrophils, eosinophils, monocytes/macrophages, dendritic 
cells and Kuppfer cells, and is defined a key role in mucosal defense. 
 12
 
2.5.3.   Leukocyte-associated immunoglobulin-like receptors    
The LAIR (leukocyte-associated immunoglobulin-like receptor) family constitutes 
together with NKp46, CD89, KIR and LILR the human LRC (leukocyte receptor gene 
complex) located on chromosome 19q13.4. LAIR1 is a type I transmembrane protein with 
one Ig-like domain in the extracellular region, and the intracellular domain harbors two 
ITIM motifs. LAIR2 is a putative secreted LAIR family member and shares 84% amino 
acid homology in the Ig- domain, but LAIR2 lacks transmembrane and inctracellular 
domains, including ITIMs 57. The LAIR family is expressed on a majority of peripheral 
blood mononuclear cells, including NK cells. Although, their role in regulating the 
immune response is unknown, the presence of ITIM motifs in LAIR1 suggests the 
receptor suppresses cellular activatory functions.  
 
 
 
Figure 3: 
Schematic structures of selected receptors expressed by NK cells. Human NKp46 and NKp30 can associate 
with homodimers or heterodimers of the FcεRIγ and CD3ζ adaptor proteins. EC, extracellular domains. IC, 
intracellular domains. The transparent shaded rectangle represents the transmembrane region. Horizontal 
interchain lines indicate disulphide bridges. 
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2.6.   The immunological synapse 
The NK immune synapse is the site of membrane apposition between the NK cell and 
target cell, and describes the clustering of receptors and their ligands. When NK cells 
encounter NK sensitive target cells, protein kinases such as Zap70, Syk and SLP-76 also 
localize to the intercellular interface together with the polarization of the microtubule 
organization center 58. Some data indicates that in the presence of a ligand for an 
inhibitory KIR, SHP-1 enters the central zone of the synapse, however, when there is no 
ligand present, SHP-1 remains in the periphery 59. Lipid rafts are microdomains in the 
cell membrane enriched in cholesterol and sphingolipids, and they have attracted 
considerable interest as they are thought to play an important role in many cellular 
processes including signal transduction 60. Even though the organization of the immune 
synapse occurs independently of SHP-1, there are evidence suggesting that SHP-1 is 
critical for blocking lipid raft polarization and thereby NK cell cytotoxicity 61. Thus, NK 
lipid raft polarization and NK immune synapse formation may reflect fundamentally 
different mechanisms. However, this is an issue of controversy, and additional 
experiments are needed to clarify the matter. 
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General techniques: 
 
 
3.1.   Polymerase chain reaction (PCR) 
In PCR, DNA is immersed in a solution containing the DNA polymerase and unattached 
nucleotides (the subunits that DNA is composed of). Primers, short nucleotide sequences 
complementary to the 5’ and 3’ end of a desired DNA segment, are added to the solution. 
When the parental doubled stranded DNA is heated to 94°C the individual strands 
unwind and separate from each other. When the solution cools, the primers attach to the 
complementary sequences on the template DNA, and DNA polymerase will quickly 
synthesize new strands by adding free nucleotides to the primers resulting in the 
formation of two double stranded molecules. When this process is repeated, a strand that 
was formed with one primer binds to the other primer, resulting in a new strand restricted 
solely to the desired segment. Theoretically the number of strands will double for each 
time the process is repeated, this allows a researcher to amplify a segment, e.g. a gene, 
into a workable amount. Some common modification may improve the amplification and 
specifictity of the PCR. Hot start requires the polymerase to be added after denaturing of 
the DNA, thereby reducing false priming. Touchdown PCR effectively reduces 
unspecific primer hybridization by programming the first cycles to have an annealing 
temperature above the theoretical Tm for primer hybridization. The annealing 
temperature then gradually decreases for each cycle until Tm is reached. Specificity can 
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also be increased by performing a second PCR using primers located inside the first pair 
of primers, a technique referred to as nested PCR. 
 
3.2.   Gel electrophoresis 
Gel electrophoresis takes advantage of the migration of charged molecules in solution in 
response to an electric field. Generally the samples are run in a support gel matrix such as 
agarose or polyacrylamide. These gels are porous and separate molecules by size by 
retarding the movement of larger molecules and allowing smaller molecules to migrate 
more freely. Because agarose gels are more rigid and easy to handle than polyacrylamide 
gels of the same concentration, agarose is used to separate large macromolecules such as 
nucleic acids.  Polyacrylamide gels are more suitable to separate proteins that require a 
small gel pore size to retard migration. Proteins are amphoteric compounds and their net 
charge is determined by the pH of the medium in which they are suspended, in addition 
the net charge carried by a protein is independent of size. As a result the separation of 
proteins at a given pH and under non-denaturing conditions is determined both by the 
size and the charge of the molecules. Sodium dodecyl sulphate (SDS) is an anionic 
detergent that binds proteins in a mass ratio of 1.4:1 by wrapping around the polypeptide 
backbone. SDS denatures the protein and confers a negative charge to the polypeptide in 
proportion to its length thus allowing the separation of proteins by molecular weight. In 
contrast nucleic acids carry a fixed negative charge per unit length of molecule. Nucleic 
acids can be visualized by staining the gel with the fluorescent dye ethidium bromide 
(EtBr), EtBr binds tightly to DNA by intercalation. Protein gels can be stained with 
Comassie brilliant blue dyes, silver stain etc, or transferred to polyvinyliden difluoride 
(PVDF) or nitrocellulose membranes for detection with specific antibodies (Western 
blot). 
 
3.3.   Computer software 
The genomic resources available are increasing at an astonishing pace. Genomic 
sequences from human, rat and mouse are available from the National Institute of Health 
(NIH) and through the EMBL project. The quality of the genomic assemblies is 
continuously improving, and the sequences can already be used to reveal a host of new 
genes.  Searches can be based on peptide or amino acid sequence similarity using 
common algorithms such as BLAST or SSAHA, or analyzes of predicted genes generated 
 16
by automated genescans. A third option is to search the database of Expressed Sequence 
Tags (EST) for homology to already known genes. The ESTs are short single pass 
sequence reads from mRNA, and represent a snapshot of genes expressed in a given 
tissue. Novel genes can be characterized “in silico” using the GCG package accessible 
through the Norwegian National EMBnet node. Such sequences can serve as template for 
primer designs to obtain full length cDNA by PCR. Other powerful bioinformatic tools 
we commonly use at our laboratory are databases and software packages available 
through the Expert Protein Analysis System (ExPASy). Such programs can be used to 
predict the function of a gene and the structure of its domains. ClustalX, a multiple 
sequence alignment program, is useful to highlight conserved features and to generate 
phylograms.  
 
3.4.   Hybridization screening 
Hybridization screening of a cDNA library has for a long time been a important tool, 
facilitating the identification of novel genes. mRNA is isolated from a given cell line or 
tissue, and converted to cDNA by reverse transcriptase (RT) PCR. The cDNA is then 
inserted into a plasmid or bacteriophage system. Most cDNA libraries used in our 
laboratory are based on the lambda ZAP vector system (Stratagene, La Jolla, CA). A 
mixture of bacteriophage and the bacterial strain MRF’ is incubated for 15 minutes to let 
the phage attach to the cells, and the mixture is then plated on NZY plates. Plaques, sites 
of infected bacteria, are visible after overnight incubation, and the plaques are lifted onto 
nylon membranes (Millipore, Billerica, MA). The membranes are treated with NaOH  to 
lyse bacteria and denature DNA, and then baked at 80°C so that DNA covalently attaches 
to the membrane. Hybridization with radioactive probes is the most sensitive method for 
detecting DNA bound to the membrane. The probe is usually a single strand cDNA 
containing the open reading frame (ORF) of a gene. Stringency determines the degree of 
sequence complementarity required for the probe to attach, and can be altered by 
adjusting the hybridization temperature and buffer composition. Prehybridization with 
sonicated salmon testes DNA prevents unspecific binding of the probe to unoccupied 
sites on the membrane. Usually hybridization is performed under low stringency 
conditions followed by high stringent washes to remove unspecifically bound probes. 
Sites of hybridization are visualized by autoradiography, and the corresponding plaque on 
the NZY plate is isolated. Phage extracted from the isolated agar is used in a secondary 
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screening, and finally a tertiary screening is performed as outlined above. The tertiary 
screening permits the isolation of bacteria solely infected with the phage containing the 
desired gene, and the lambda ZAP vector is subjected to in vivo excision. This releases 
the pBluescript phagemid contained in the lambda ZAP vector, and permits the insert to 
be characterized in a plasmid system. 
 
 
 
 
 
 
 
 
Flow chart describing a bacteriophage cDNA library screening: 
 
 
 
 
 
 
Hybridization protocol: 
 
• Membranes are prehybridized for four hours in rotating bottles at 42°C in 50% 
deionized formamide, 5 x SSC, 50 mM NaPi pH 6.5, 250 µg/ml sonicated 
salmon testis DNA (Sigma-Aldrich, St Louis, MO), 5 x Denhardt’s solution and 
0.1% SDS.  
• The probe is radiolabeled with [32 P] dCTP using a random nonamer protocol 
(Megaprime DNA labeling system, Amersham International, Little Chalfront, 
GB) and hybridized in rotating bottles at 42°C for 16-20 hours in 50% deionized 
formamide, 5 x SSC, 50 mM NaPi pH 6.5, 250 µg/ml sonicated salmon testis 
DNA (Sigma-Aldrich), 5 x Denhardt’s solution and 0.1% SDS. 
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• Membranes are finally washed 4 x 5 min. at room temperature in 2 x SSC/0.1% 
SDS, followed by two high stringency washes at 50°C for 30 min. in 0.2 x SSC/ 
0.1% SDS and then subjected to autoradiography.  
 
3.5.   Radiation hybrid (RH) mapping 
Chromosomal localization of novel genes in the mouse and rat can easily be verified 
using a technique referred to as RH mapping. An RH panel clone is created by fusing an 
irradiated rat or mouse cell line with hamster cells, and the full panel consists of 106 RH 
clones, each clone containing unique combinations of fragments of rodent genomic DNA. 
The panel is analyzed by standard PCR technique using primers specific for the gene 
being investigated. Each gene will have their own exclusive fingerprint given by the 106 
RH clones yielding a PCR product of desired length, indicating that the clone holds part 
of the genome containing the gene of interest. This fingerprint can then be compared to a 
framework of markers whose chromosomal localization are known. Our data are based 
on T31, a mouse/hamster RH panel (Research Genetics, Huntsville, AL), and the T55 
rat/hamster panel (Research Genetics). 
 
• The T31 mouse/hamster panel was analyzed with mouse Kir3dl1 specific primers 
(5’- TGATGGGCCCTGTGCTGATGATG -3’, 5’- 
CCTCGAATTTACCACTGTGGCTCCTG -3’) for the presence of a 150-bp 
product, and with primers specific for mouse NKp46 (5’- 
CCAAACCCAGCATCATGGTCACAAT -3’, 5’- 
AGTTTCAGGGGGTTGCTCGACTT -3’) yielding a 240-bp product. 
• Chromosomal localization of rat Kir3dl was determined using gene specific 
primers (5’- TGCCTCGCCAAGTTATATTGTTCCTC -3’, 5’- 
TCACTATGCGCTGAAATTTCATTAGGGT -3’), resulting in a 230-bp PCR 
fragment.  
 
3.6.   Southern Blot 
Southern Blots can determine whether or not multiple related genes exist. A genomic 
southern blot is generated by digesting DNA with a given restriction enzyme, the DNA 
fragments are then separated by agarose gel electrophoresis and transferred to a nylon 
membrane. A single strand cDNA probe based on the gene of interest will hybridize with 
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complementary sequence, and can be visualized by labeling it with a radioactive isotope. 
A large number of bands in a lane indicate the existence of multiple related genes in the 
genome. 
 
Protocol: 
 
• DNA extracted from rat liver, digested with restriction endonuclease (New 
England Biolabs, Beverly MA) is subjected to horizontal agarose gel 
electrophoresis and blotted onto a Biotrans nylon membrane (ICN Biochemicals, 
Irvine, CA) as described elsewhere 62. Hybridization to a radiolabeled probe is 
performed in 50% formamide, 5 x SSC, 50mM sodium phosphate pH 6.5, 250 
µg/ml sonicated salmon testes DNA (Sigma-Aldrich), 5 x Denhardt’s solution and 
0.1% SDS at 42°C for 16-20 hours in a hybridization oven. Membranes are then 
washed 4 x 5 min. in 2 x SSC/0.1% SDS at room temperature, then 2 x 30 min. at 
50°C in 0.1 x SSC/0.1% SDS. Where low stringency hybridization is required, 
hybridization temperature is lowered to 37°C, and final washes are carried out at 
45°C in 1 x SSC/0.1% SDS for 2 x 30 min. 
 
3.7.   Reverse transcriptase (RT) PCR 
RT-PCR is well suited to study the cellular expression of a certain gene and to quantitate 
the mRNA levels, i.e. establishing quality and quantity of gene expression. Total cellular 
RNA is isolated and subjected to first strand cDNA synthesis. The resultant cDNA 
mirrors the protein expression pattern of a certain cell type or tissue, and then functions 
as a template for regular PCR using primers specific for the gene of interest. Using 
primers from neighboring exons excludes the possibility of genomic contamination, as 
genomic DNA contains the intervening intron and yield fragments of greater length. 
 
• First strand cDNA synthesis was performed by adding 1µg of total cellular RNA , 
20U of RNasin ribonuclease inhibitor (Promega, Madison, WI), 0.75mM of each 
dNTP and 35ng of oligo(dT)15 primer (Promega) to 20µl standard MMLV RT 
reaction buffer (Promega) and heating to 80°C for 5 min. Then, 200U of MMLV 
RT, RNase H minus (Promega) was added together with additional 16U RNasin, 
and the mixture was incubated at 37°C for 1 hour. The enzyme was inactivated at 
 20
81°C for 5 min., and PCR was performed on the cDNA with primers specific for 
the gene of interest. 
• Mouse Kir3dl1 expression was analyzed by PCR (35 cycles) using primers 
specific for the first (5’- CCTATCTGCCTGGCCAAGTTATG -3’) and second 
(5’- TCACATTCCCTCCTGTATCCACC -3’) Ig exons on first strand cDNA 
from C57BL/6 lymph node T cells (Pan T cell isolation kit; Miltenyi Biotec, 
Bergisch Gladbach, Germany), or IL-2 activated spleen NK cells cultured in rat 
IL-2 as described elsewhere 63. 
• A primer pair specific for the first (5’- CTGTGCCTCGCCAAGTTATATTGTTC 
-3’) and second (5’- AATGACACTCCAGGGTCACATTCTC -3’) Ig exons of rat 
KIR3DL1 was used to analyze transcription by PCR (25 cycles), total RNA 
isolation was performed as described previously 64. 
 
3.8.   Generation of expression constructs 
Epitope-tagged expression constructs are useful to dissect proximal signaling events.  
The Kozak sequence and ORF of a desired gene is amplified by PCR using primers 
containing restriction sites corresponding to the restriction sites incorporated into the 
multiple cloning site (MCS) of the expression vector. The PCR products are cloned into 
the pCR 2.1-TOPO vector (Invitrogen, San Diego, CA), and the fragment of interest 
released by digestion with restriction enzymes. The fragment can then be inserted into the 
MCS of a given expression vector. 
 
 
The mKIR3DL1 FLAG-tagged expression construct was generated as follows: 
 
• The ORF of mouse Kir3dl1, excluding leader sequence, was amplified with the 
primer pair; 5’- AAGCTTTTGCCAGCCATGCTGCTC -3’, 5’- 
GGATCCGGTGCAGACATTCTTTGATCTC -3’, containing HindIII and 
BamHI restriction sites respectively. The PCR products was cloned into the 
pCR2.1-TOPO vector (Invitrogen) according to manufacturers instructions, 
followed by digestion with HindIII and BamHI (New England Biolabs) to release 
the gene fragment with HindIII and BamHI overhangs. Finally the fragment were 
ligated into the expression vector pCMV-FLAG-1 (Sigma-Aldrich).  
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3.9.   Transfection and immunoprecipitation 
The transfection system often used in our laboratory is based on  293T cells, a human 
embryonic kidney cell line. Cells are transiently transfected using lipofectamine, a 
liposome formulation creating DNA-lipid complexes. Cationic lipids form such 
complexes due to the electric interactons between the negatively charged backbone of 
DNA and the positively charged lipids. These complexes fuse with the cell membrane by 
mechanisms not completely understood, and show a high transfection activity in most 
adherent cells. Cells are then lysed, the proteins are separated by electrophoresis in a 
polyacrylamide gel and then transferred to a nitrocellulose membrane. The membrane is 
incubated in a buffer containing a specific antibody against the protein of interest and 
visualized with a fluorescent dye labeling the antibody. To study protein-protein 
interactions the cell lysate can be subjected to immunoprecipitation. A desired protein 
and possible adaptor proteins can be precipitated by adding an antibody that specifically 
binds the particular protein. The antibody-protein complex is removed from solution by 
the addition of an insoluble form of an antigen binding protein such as protein G-
sepharose beads. The beads are isolated by centrifugation, and after extensive washing 
immunoprecipitated material can be eluted from the beads by boiling it in a SDS-
containing electrophoresis sample buffer. The eluate is then fractionated by SDS-PAGE 
and analyzed by Western blotting.   
 
 
Transfection protocol: 
 
• Adherent 293T cells are released in PBS containing 0.5mM EDTA, recultivated 
in RPMI 1640 (Invitrogen, San Diego, CA) with 1mM sodium pyruvate and then 
incubated for 24 hours. A 70-80% confluence upon transfection is considered 
optimal. Prior to transfection cells are washed three times in PBS, pH 7.4, in order 
to remove traces of serum. 
• For transfections using 25 cm2 flasks, 5 µg of plasmid DNA is added to 0.25 ml 
Opti-Mem (Invitrogen) and subsequently mixed with a solution of 0.25 ml Opti-
Mem (Invitrogen) containing 20 µl Lipofectamin (Invitrogen). The mixture of the 
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two solutions is incubated at room temperature for 30 min., before being diluted 
in 1.8 ml Opti-Mem (Invitrogen) and finally added to the cells. 
• After 6 hours incubation at 37°C, 2.5 ml of RPMI supplemented with 20% FCS is 
cautiously poured into the flask. Following another 18 hours, the cell medium is 
replaced with RPMI containing 10 % FCS. Facs flow analysis or cell lysis should 
be performed within the next 24-48 hours. 
 
Western Blot protocol: 
 
• Cells are lysed for 30 min. in 1% Igpal CA-630 (Sigma-Aldrich), 20mM TrisHCl, 
100mM NaCl, 10mM NaF, 10mM NaPPi, 1mM Na3VO4, 5mM EDTA and a 
protease inhibitor mixture (Sigma-Aldrich), followed by centrifugation; 13000 
rpm in a microcentrifuge for 30 min at 4°C, and the supernatant (WCL) collected. 
• The PVDF membrane (Millipore) is activated in methanol for 15-30 seconds, the 
gel and activated membrane are sandwiched between filter papers saturated with 
transfer buffer (25mM Tris base, 192mM Glycine, 10% methanol), and for each 
layer air bubbles are removed. 
• Membranes are blocked with 5% non-fat dry milk in TBS containing 0.05% 
Tween20 for 1 hour (membranes intended for detection with 4G10, anti-
phosphotyrosine mAb, are blocked with 3% Bovine Serum Albumin), followed 
by incubation with 1 µg/ml rabbit anti-FLAG ab (Sigma-Aldrich), or 0.2 µg/ml 
4G10(Santa Cruz Biotechnology, Santa Cruz, CA) mAb fot at least 4 hours, 
succeeded by 6 x 5 min. washes in TBS. The membranes are then subjected to 
secondary incubation with goat anti-rabbit, or goat anti-mouse (anti igG2b) HRP 
conjugated mABs (Jackson ImmunoResearch Laboratories, West Grove, PA) for 
1 hour and finally washed 6 x 5 min. in TBS. Chemiluminiscense detection is 
performed using SuperSignal substrate (Pierce, Rockford, IL) and captured on 
BioMax MR film (Eastman Kodak, Rochester, NY) or by digital camera, 
ImageStation 2000R (Eastman Kodak). 
 
3.10.   Molecular cloning of rodent LAIR, rodent LILR and rat CD89: 
An unpublished cDNA sequence encoding mouse Lair was retrieved (GenBank accession 
number AF479685), and 5’UTR and 3’UTR gene specific primers were generated. Based 
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on sequence similarity to mouse Lair, exons encoding a rat Lair variant were recovered, 
including 5’UTR and 3’UTR sequences. Genes encoding rat and mouse Lair were 
amplified by standard touchdown PCR from spleen mRNA, harvested from PVG rats and 
C57BL/6 mice. 
 
Mouse and rat LilrA1 (leukocyte immunoglobulin-like receptor) were predicted on the 
basis of current mouse and rat genomic sequences 
(http://www.ensembl.org/Mus_musculus/; http://www.ensembl.org/Rattus_norvegicus/), 
exons were retrieved based on amino acid sequence similarity to human LILR sequences. 
5’UTR and 3’UTR were obtained by extending the leader sequence upstream and the 
cytoplasmic sequence downstream respectively. The genes were amplified by PCR 
analogous to Lair as described above. 
 
Rat CD89 was retrieved by the detection of an EST containing the 3’UTR (GenBank 
accession number AI112904 ). A primer specific for 3’UTR was generated, and the 
cDNA amplified from Marathon-ready cDNA according to the manufacturer’s 
instructions (BD Biosciences-Clontech, Franklin Lakes, NJ). The PCR product was 
sequenced and a 5’UTR primer generated. Finally, the gene was amplified from PVG 
spleen mRNA. 
 
Rat LilrA2 was detected following searches for genes with homology to rat LilrA1. 
Forward and reverse primers specific for the second Ig-like domain were generated (5’- 
TGGGTCGTAGAGTCGGTATGGTT -3’; 5’- AGAGTCCATACCAGTCAAGGGTC -
3’), and the 3’- and 5’- gene fragments amplified from Marathon-Ready cDNA (BD 
Biosciences-Clontech). The partial genes were sequenced in order to disclose 3’UTR and 
5’UTR, and the gene was then amplified from rat PVG mRNA as described above. No 
mouse equivalent to rat LilrA2 has been detected. 
 
The following 5’UTR and 3’UTR primers specific for CD89, LilrA1, LilrA2 and Lair 
were generated: 
Gene 5’- UTR primer 3’- UTR primer 
Rat  GGTCTGAGGCCATATC ATCATCAGGGGAAGCCAGGGTAG 
 24
 
 
 
Summary of paper 
 
 
4.2.   Cloning of KIR receptors in the mouse and rat: 
By extensive searches in EST databases for homology to the human KIR2DL4 gene, two 
promising candidates were retrieved in mouse (GenBank accession numbers: BB644731 
and BB314335). This gave hope that the gene was actually expressed at some level. 
Mouse trace archives, repositories of raw sequence traces generated by the mouse 
sequencing project, was searched for homology to the EST sequence. Trace sequences 
were then assembled in a stepwise manner, and finally a genomic contig containing all 
the exons and introns of the KIR gene was completed. Based on these sequences PCR 
primers were synthesized, and the gene was successfully amplified by PCR from a mouse 
NK cell library. The gene shared many structural features with the KIR3DL variant in 
human, and consisted of three extracellular IgSF domains, a stem region, a 
transmembrane region lacking charged amino acids and a cytoplasmic region containing 
one pair of ITIM motifs. 
  
This was prior to the first release of the mouse genome sequence and moreover, no 
genomic assemblies containing the gene were accessible at the time. We therefore 
CD89 
Rat  
LilrA1 
TGCCATGACCTTCATCTTCACAGCC GACCCAAACCTGACTGATGAAACAAGA 
Rat  
LilrA2 
TCCTGATGGTCACTGTAGTGTCATTT CTATCCCAATTGCATAAGTGTGGAGT 
Rat  
Lair 
CAGACCTGGTAAGGTTGCTGGA CTGGGCTCATTACACAACTGGG 
Mouse  
Lair 
TGCAGGGCTTCTGCTCTGAC GAAGAGGCCTGGCAGTGAGA 
Mouse  
LilrA1 
TGCCATGACCTTCGTCTTCACAG TGGCCATAGAAGAATTTTCCACCCAAG 
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performed a hybridization screening using the full length PCR fragment as probe to 
identify closely related genes. Analysis of genomic trace sequences led to the suspicion 
that there existed at least two variants of the gene, but the hybridization screening only 
identified the variant obtained by PCR.  
 
Parallel to the hybridization screening in mouse, the full length PCR clone was used as 
template for homology searches in rat trace archives. A similar cloning approach as 
described above was performed in the rat, and the hybridization screening identified 
several splice variants. Four different polyadenylation sites were observed, and cryptic 
splice sites were present in the second signal peptide exon, the transmembrane exon and 
importantly in the cytoplasmic exon leading to the loss of both ITIMs. In addition the 
transmembrane domain contained a trinucleotide repeat yielding an abnormally long 
transmembrane region. Altogether, these findings suggest that the gene may be a 
pseudogene, even though the large number of cDNA clones detected in the library 
screening and the readily detectable levels of mRNA demonstrated by RT-PCR indicate a 
high level of transcription in NK cells.  
 
When the preliminary mouse genome sequence was published, it became clear that there 
exist two KIR variants in the mouse. We made several unsuccessful attempts to amplify 
the second gene by PCR from different NK cell libraries as well as RNA isolated from 
spleen and blood. The original ESTs were based on mRNA harvested from brain tissue, 
and the unexpected tissue expression might explain why cloning attempts have been 
futile. Analysis of rat genomic assemblies leaves no evidence in support for the existence 
of more than one KIR variant in rat. 
 
4.2.1.   Cellular expression: 
Semiquantitative RT-PCR analysis demonstrated that Kir3dl1 is selectively transcribed 
by NK cells in both mouse and rat. After additional cycles of PCR a weak band was 
detected in mouse lymph node T cells, possibly due to a small number of NK cells in the 
lymph node T cell preparation. No transcription was detected in rat T cells.  
 
4.2.2.   Chromosomal localization: 
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In the human the KIR family is located in the leukocyte receptor gene complex (LRC) on 
chromosome 19q13.4. The gene family comprises 16 members with several allelic 
variants and two pseudogenes. The KIR genes are clustered tightly in a head to tail 
fashion and span 100-150kb of genomic sequence. In the rat, RH screening localized the 
Kir3dl1 receptor to the LRC on chromosome 1 as expected. Interestingly, screening a 
mouse/hamster RH panel reproducibly localized the mouse gene to the X chromosome. 
To exclude the possibility of a local error in the RH marker framework, the panel was 
screened with primers specific for mouse NKp46. NKp46 localizes to the LRC in both 
human and mouse, and is closely linked to the KIR gene cluster in the human genome. 
The NKp46 RH distribution pattern differed from the pattern obtained for Kir3dl1, and 
localized NKp46 to the mouse LRC on chromosome 7. There is growing evidence for the 
translocation of a region in the mouse LRC on chromosome 7 that can explain these and 
other findings as will be discussed later. 
 
 
4.2.3.   Surface expression of KIR: 
A mouse KIR3DL1-FLAG construct induced surface expression of KIR3DL1 when 
transiently transfected in 293T cells. This was demonstrated by flow cytometry as well as 
western blots of whole cell lysates and immunoprecipitates yielding a 55kDa band under 
non-reducing conditions. Anti-FLAG immunoprecipitates probed with an anti-
phosphotyrosine mAb yielded a similar major band, and may indicate the recruitment of 
SHP-1. An additional weaker 110 kDa band was observed in some experiments, 
suggesting that mouse KIR3DL1 partially exists as a disulfide-linked dimer in 293T cells. 
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Present studies 
 
 
4.1.   Scope of the thesis 
This thesis is divided into two parts. The first and major part describes the cloning and 
characterization of rodent orthologs to the human KIR family. This discovery led 
ultimately to the identification of other rodent orthologs to human genes. The specific 
aims of the work were to: 
 
a) Analyze genomic trace sequences and ESTs available to detect the presence KIR 
orthologs in the mouse and rat genomes. 
 
b) Identify and characterize the receptors if discovered.   
 
c) Determine phylogenic relationship, chromosomal localization and tissue expression of 
rodent KIR. Finally, generate expression constructs in order to verify surface expression 
of the receptor. 
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As we succeeded in identifying rodent KIR orthologs, we decided to extend our search to 
include other rodent genes. Genome assemblies had just become available, and this led us 
to:  
 
e) Generate gene maps of the LRC in mouse and rat based on genomic assemblies and 
furthermore, resolve similarities and differences with regard to the human LRC.  
 
f) Identify and characterize novel rodents genes, in specific rodent orthologs to human 
CD89. 
 
5.2.   The leukocyte receptor gene complex (LRC) 
The human LRC on chromosome 19q13.4 contains 45 genes including a selection of 30 
genes encoding Ig-like receptors. The centromeric part of the complex is limited by a 
group of genes unrelated to the Ig-like receptors, the LRC-encoded novel genes 
(LENGs). The telomeric end of the complex is comprised of a group of structurally 
related genes including CD89, NKp46 and GPVI 39. The organization of its syntenic 
regions in mouse and rat is less clear, but some findings are puzzling:  
1) KIR receptors in mouse are located on chromosome X, and the Gp49 family (Ig-
like receptors which are related to the LILR family in human) is positioned on 
chromosome 10.  
2) In contrast, the LRC in the rat appears to be intact, and shares structural similarity 
with the human LRC, also regarding Gp49s and KIR.  
3) Despite extensive effort, no CD89 ortholog has been identified in the mouse, and 
importantly, the presence of a rat ortholog has largely remained uninvestigated. 
4) No rodent orthologs of human LAIR have been identified. 
 
5.2.1.   Identification of a rat CD89 homolog 
Analyzing the mouse genomic assembly, NCBI build 30 (http://www.ensembl.org/ 
Mus_musculus/), a retroviral integration site was retrieved at the locus syntenic to the 
localization of human CD89, upstream for NKp46. In human, the neighboring KIR locus 
is positioned further upstream for CD89. No CD89 ortholog was detected in the mouse 
genomic assembly, however analyzing rat genomic sequences a promising candidate was 
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detected at the predicted site between NKp46 and Kir3dl1. Based on the human CD89 
cDNA sequence all exons were retrieved, and primers specific for the 5’UTR and 3’UTR 
regions generated. The gene was successfully amplified from a PVG spleen cDNA 
library, and subsequent sequencing indicates that the gene does indeed represent a rat 
CD89 ortholog. KIR is in rat localized upstream for the CD89 ortholog and the Gp49s are 
located upstream of the Kir3dl1, analogous to the organization of the human LRC 
provided that Gp49s share common parentage with the human LILR family. Together, 
these findings make it tempting to speculate that the integration of a virus or transposable 
element in the mouse genome, led to the accidental loss of mouse CD89 and the 
translocation of Gp49 and KIR. 
 
 
Figure 4: 
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Amino acid sequence of rat CD89 aligned with human and bovine CD89 (GenBank accession number 
X54150 and AY247821, respectively). The alignment was generated by ClustalX, and gaps were 
introduced to maximize homology. Identical amino acids are represented by dashes. Conserved cysteines in 
the extracellular domains (involved in the creation of disulfide bonds) are indicated by green asterisks. Blue 
boxes identify N-linked glycosylation sites (NxS/T). Arginine present in the transmembrane domain, 
permitting association with the FcεRIγ, is colored red. Predicted amino acid sequence of rat CD89 is 54% 
identical to human CD89 and 54% identical to bovine CD89.   
 
5.2.2. Cloning of a  Leukocyte-Associated Immunoglobulin-Like Receptor (Lair) 
in the mouse and rat, and a novel family of Ig-like receptors. 
Following the approach outlined above, rat and mouse orthologs of human LAIR were 
identified and successfully cloned, and in addition a novel family of receptors in the 
mouse and rat LRC detected, denoted LILR.  
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Figure 5: 
Amino acid sequences of mouse LilrA1, rat LilrA1 and rat LilrA2 aligned with human ILT11 and human 
LILRA1b. LILRA1b appears to be an alternatively spliced variant of LILRA1a, but differs in the absence of 
the third and fourth Ig-like domain of LILRA1a. Cysteines are indicated with green asterisks, and blue 
boxes represent N-linked glycosylation sites. Arginine present in the transmembrane domain is colored red 
(arginine allows association with the FcεRIγ in the human). Comparisons of the predicted amino acid 
sequences of mLilrA1and rLilrA1 with hILT11 and hLILRA1, reveal that these genes are closely related. 
Mouse and rat LilrA1 are 84% identical to each other, between 56-58% identical to hILT11 and 54% 
identical to hLILRA1b. The predicted amino acid sequence of rLilrA2 is 51% identical to rLilrA1, 57% 
identical to hILT11 and 55% identical to hLILRA1b. 
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Figure 6: 
Amino acid sequences of mouse and rat Lair1 aligned with human LAIR1 (GenBank accession number 
AAB69324). Cysteines are indicated with green asterisks, and blue boxes represent N-linked glycosylation 
sites. Intracellular ITIM-motifs (potentially involved in signal transduction by binding SHP-1) are colored 
red. mLair1 and rLair1 are 72% identical to each other, and 48% and 46% identical to hLAIR1 respectively. 
 
The predicted overall structure of these receptors conforms to a type I transmembrane 
protein comprised of two extracellular Ig-domains, a transmembrane domain containing 
the charged amino acid arginine, suggesting interaction with adaptor proteins such as 
FcεRIγ and DAP12, and a short cytoplasmic region devoid of any signaling motifs. These 
receptors do not represent a “missing link” between the human LILR family and the 
rodent Gp49 and Pir families. However, as depicted in the dendrogram, human LILR and 
rodent Gp49, Lilr and Pir do constitute a distinct family, and obviously share common 
ancestry. Probably, strain to match the fast diversification of pathogens led to expansion 
of the family, and in rodents the family over time separated into three largely related 
subclasses.   
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Figure 7: 
Schematic representation of human LILRB3 and novel rodent LILR genes, along with CD89, LAIR, 
NKp46 and KIR. The horizontal lines at the top indicate the species in which known homologs have been 
identified. Ligands for the various receptors are shown in the boxes at the top of each receptor. EC, 
extracellular domains. IC, intracellular domains. The transparent grey line represents the transmembrane 
region. Horizontal interchain lines indicate disulphide bridges. 
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Figure 8: 
Phylogram displaying similarity between the novel family of rodent LILR receptors, rat CD89, rat Lair and 
selected IgSF leukocyte receptors in the LRC. Amino acid sequences of each receptor were aligned using 
ClustalX, and tree topology was estimated by neighbor-joining where branch values represent the number 
of bootstrap support after 1000 replications. Colors highlight closely related genes. hFcg2b is defined as an 
outgroup. h, Homo sapiens; m, Mus musculus; r, Rattus norvegicus; bt, Bos taurus (cattle).  
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Figure 9: 
Genomic organization of the LRC in human, mouse and rat, based on available genome assemblies 
(http://www.ensembl.org; http://www.ncbi.nlm.nih.gov). The human19q13.4 region is depicted along with 
its syntenic regions on mouse chromosome 7 and rat chromosome 1. The ribosomal protein RPS9 
represents the centromeric border of the LRC, and NKp46 limits the locus at the telomeric end. Several 
genes encoding LILR receptors, PIRs, KIRs as well as several non-IgSF genes have been omitted for 
clarity. Diagonal lines represent possible errors in the rat assembly, the present assembly is also in conflict 
with our obtained RH data.  A reconstructed assembly consistent with our data has been included. Human 
sequence containing NKp46, CD89, KIR and the telomeric LILR cluster are together with equivalent 
regions in the mouse and rat genomes, demarcated with transparent yellow boxes. The viral integration site 
present in mouse, possibly representing the site of translocation is denoted with a dark blue box.  
*PirA6 has not been characterized in the rat. PirA6 as depicted in the rat LRC represents genomic sequence 
sharing amino acid similarity to mouse PirA6, suggesting the presence of a rat PirA6 homolog. 
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V.   Discussion
 
 
HLA matched allogeneic hematopoietic transplantations have revolutionized the 
treatment of leukemia and lymphoma. T-cells contained in the transplant are vital in 
eradicating malignant cells (graft verses leukemia effect GVL) and in reconstituting 
immunity, but unfortunately the T-cells attack other tissues in the recipient as well (graft 
verses host disease GVHD). Recently, knowledge of the KIR receptors have led to 
radically improved outcome in the treatment of acute myeolid leukemia (AML). It is 
believed that the KIR receptors expressed by an NK cell precursor are determined by 
random processes, and that NK cells expressing receptors for self HLA class I molecules 
are selected. Thus, NK cells from any given person will be alloreactive toward cells from 
other individuals who lack their KIR ligands, and conversely, tolerant of cells from an 
individual who shares the same KIR ligands. Clinical transplantations in a group of high 
risk leukemia patiens lacking a HLA matced donor have shown that mismatching the 
three major KIR ligands; HLA-C group 1,2 and HLA-Bw4, protect patients from 
rejection, AML relapse and unexpectedly reduce the severity of GVHD 65. The reason 
why alloreactivity does not cause GVHD but actually protects against it is believed to be 
alloreactive NK cells killing recipient antigen presenting cells 65. Alloreactive NK cell 
infusions have the potential to improve outcome even further and are of great therapeutic 
interest. 
 
By cloning the first KIR receptors in rodents better animal models may be introduced in 
the ongoing investigations of the KIR receptors, but first we need to clarify if the 
receptors play a similar role in rodents as they do in human. Some of the techniques 
summarized below will be of interest regarding other novel receptors we have identified, 
and will hopefully divulge some important results. 
 
The mouse KIR3DL1 receptor contains two ITIM motifs in the cytoplasmic domain 
indicating an inhibitory function. The next step is to elucidate the receptors signaling 
mechanisms and to resolve the function of the protein. A chimeric construct comprising 
the CH2 and CH3 domains of mouse IgG2b heavy chain bound to the extracellular 
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domains of KIR3DL have been made. Soluble fusion protein can be generated by 
transfecting 293T cells with the construct, followed by protein purification on a protein G 
column. Finally, rats will be immunized with the fusion protein over a three month 
period. We have previously succeeded in generating several antibodies at our laboratory 
using this method. An antibody gives us the opportunity to carry out 
immunoprecipitations and facs flow analysis on cells isolated from mice, and will be an 
important tool in dissecting the proximal signaling events as well as performing 
expression studies.  
 
RNKDA1 is a rat NK cell line isolated from DA rats. This cell line provides a better model 
for in vitro studies than 293T cells. Stable transfection of these cells with KIR3DL1 can 
be achieved by electroporation with a linearized plasmid containing the gene and a 
selection marker. Cytotoxicity assays will complement the studies of signaling 
mechanisms, and give us important information about the receptors effector functions.  
 
The identification of the ligands is of pivotal importance, but may prove difficult to 
accomplish. The KIR-Fcγ2b fusion protein can be used as a probe in facs flow analysis 
binding transfected target cells, but the method may turn out elaborate and time 
consuming even though MHC class I molecules are suspected ligands. Another attractive 
approach is to utilize a green fluorescent protein (GFP)-reporter cell line made by Arase 
and Saito, these cells are stably transfected with a GFP controlled by NF-AT. The cell 
line is transfected with a chimeric construct comprising the extracellular domains of 
KIR3DL1 bound to the transmembrane and cytoplasmic parts of the TCR ζ chain. If these 
cells are incubated with target cells expressing a ligand for KIR3DL1, NF-AT is activated 
by the TCR ζ part of the chimeric protein, and the cells turn green following a few hours.  
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